[1]
T. Hernández Casola, H. Pérez Nápoles, D. Torrecilla Silverio, and I. Companioni de la Cruz, “Report of adverse events to the CIMAvax-EGF vaccine in patients with non-small cell lung cancer”, BJM, vol. 11, no. 2, pp. 15–18, Oct. 2023.